Premier Alternatives

Nanopath

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.

PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025

Nanopath key facts

as of Oct 2026
  • Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis.
  • Nanopath is valued at approximately $32.0M as of Oct 2026, set at its early-stage round, Aug 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $16.4M across 2 recorded rounds; the latest was Debt ($5.3M) in Jan 2025.
  • Notable investors include Alumni Ventures, Creative Destruction Lab, US National Science Foundation, Service Provider Capital, National Institutes of Health — 17 tracked in total.
  • Nanopath has filed 2 Form Ds with the SEC since 2022, most recently Feb 2025 ($5.3M sold to 5 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$32.0M

Valued at $32.0M at its early-stage round, Aug 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Nanopath with a free account
  • ·The complete investor list: 17 names
  • ·Watch Nanopath: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nanopath funding rounds

2 rounds
Jan 2025Debt$5.3MSEC filing▮
Jun 2022Early Stage VC$10.0MSEC filing▮
Full funding history →

Nanopath valuation

Nanopath was valued at $32 million at its early-stage round in Aug 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Nanopath raised?

Nanopath has raised $16.4 million across 2 recorded rounds since 2022. The largest was a $5.3 million debt round in Jan 2025.

Nanopath has filed 2 Form Ds with the SEC since 2022, most recently in Feb 2025 ($5.3 million sold to 5 investors).

Nanopath investors

17 investors are on record for Nanopath, including Alumni Ventures, Creative Destruction Lab, US National Science Foundation and Service Provider Capital. By type, the record holds 4 venture capital firms and 1 family office. The debt round in Jan 2025 drew 5 investors.

About Nanopath

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. The company's technology eliminates the need for nucleic acid amplification and supports multiplexed detection, enabling patients and providers to access actionable diagnostic results within standard office visits for improved healthcare outcomes.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2019
Employees
23
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.